TransMedics Group (TMDX) remains a Sell due to high valuation and decelerating revenue growth despite recent earnings ...
Samvat 2082 will start today. Every investor must be praying that it does not usher in fresh uncertainty as did Samvat 2081.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果